| Abivax SA | 2.05M | US$203M | 9.3% |
| State Street SPDR S&P 500 ETF | 178K | US$135M | 6.2% |
| Protagonist Therapeutics, Inc. | 951K | US$134M | 6.1% |
| Roivant Sciences Ltd. | 3.08M | US$113M | 5.1% |
| Immunovant, Inc. | 2.12M | US$71.5M | 3.3% |
| Denali Therapeutics Inc. | 2.07M | US$42.8M | 2.0% |
| Alpha Architect 1-3 Month Box ETF | 337K | US$39.9M | 1.8% |
| Septerna, Inc. | 974K | US$38.1M | 1.7% |
| Agios Pharmaceuticals, Inc. | 1.14M | US$37.9M | 1.7% |
| Aura Biosciences, Inc. | 5.39M | US$33.8M | 1.5% |
| Viking Therapeutics, Inc. | 1.03M | US$33.7M | 1.5% |
| Cytokinetics, Incorporated | 461K | US$30.4M | 1.4% |
| Insmed Incorporated | 230K | US$26.2M | 1.2% |
| Freenome, Inc. | 1.65M | US$25.9M | 1.2% |
| Celldex Therapeutics, Inc. | 799K | US$25.9M | 1.2% |
| Anteris Technologies Global Corp. | 3.24M | US$25.2M | 1.1% |
| BridgeBio Pharma, Inc. | 379K | US$25M | 1.1% |
| Praxis Precision Medicines, Inc. | 84,751 | US$24.7M | 1.1% |
| Fulcrum Therapeutics, Inc. | 6.65M | US$24.6M | 1.1% |
| Vir Biotechnology, Inc. | 2.16M | US$24.1M | 1.1% |
| DBV Technologies SA | 2.01M | US$23.6M | 1.1% |
| Enanta Pharmaceuticals, Inc. | 1.73M | US$22.8M | 1.0% |
| Editas Medicine, Inc. | 8.89M | US$22.8M | 1.0% |
| Spyre Therapeutics, Inc. | 238K | US$21.2M | 0.96% |
| Enliven Therapeutics, Inc. | 443K | US$20.3M | 0.92% |
| Nurix Therapeutics, Inc. | 813K | US$19.3M | 0.88% |
| Sanofi SA | 465K | US$19.2M | 0.87% |
| Revolution Medicines, Inc. | 87,509 | US$18M | 0.82% |
| Sarepta Therapeutics, Inc. | 952K | US$17.3M | 0.79% |
| Maze Therapeutics, Inc. | 637K | US$17.3M | 0.79% |
| Adlai Nortye Group Ltd. | 997K | US$16M | 0.73% |
| Rallybio Corporation | 926K | US$15.9M | 0.73% |
| Nektar Therapeutics | 258K | US$15.6M | 0.71% |
| Taysha Gene Therapies, Inc. | 3.06M | US$14.9M | 0.68% |
| Monopar Therapeutics Inc. | 179K | US$14.3M | 0.65% |
| Janux Therapeutics, Inc. | 824K | US$14.2M | 0.65% |
| Rhythm Pharmaceuticals, Inc. | 139K | US$13.2M | 0.60% |
| Cogent Biosciences, Inc. | 392K | US$12.6M | 0.57% |
| Regeneron Pharmaceuticals, Inc. | 16,446 | US$12.5M | 0.57% |
| State Street SPDR Bloomberg 1-3 Month T-Bill ETF | 136K | US$12.4M | 0.57% |
| Tenax Therapeutics, Inc. | 6.52M | US$12.3M | 0.56% |
| Monte Rosa Therapeutics, Inc. | 1.01M | US$12M | 0.55% |
| AbCellera Biologics Inc. | 822K | US$12M | 0.55% |
| Establishment Labs Holdings Inc. | 186K | US$11.9M | 0.54% |
| Vogenx Inc | 522K | US$11.9M | 0.54% |
| Inhibikase Therapeutics, Inc. | 5.71M | US$11.7M | 0.53% |
| Ovid Therapeutics Inc. | 4.56M | US$11.4M | 0.52% |
| Avalyn Pharma Inc. | 398K | US$11.3M | 0.52% |
| Amylyx Pharmaceuticals, Inc. | 367K | US$10.7M | 0.49% |
| Helix Acquisition Corp. III | 1M | US$10.5M | 0.48% |
| Beam Therapeutics Inc. | 421K | US$10.3M | 0.47% |
| Vor Biopharma Inc. | 531K | US$10.1M | 0.46% |
| Edgewise Therapeutics, Inc. | 243K | US$9.87M | 0.45% |
| Kazia Therapeutics Ltd | 968K | US$9.29M | 0.42% |
| Climb Bio, Inc. | 793K | US$9.09M | 0.41% |
| Replimune Group, Inc. | 656K | US$8.68M | 0.40% |
| Opus Genetics, Inc. | 1.78M | US$8.63M | 0.39% |
| Summit Therapeutics Inc. | 497K | US$8.4M | 0.38% |
| Vaxcyte, Inc. | 146K | US$8.31M | 0.38% |
| Research Alliance Corporation III | 767K | US$8.31M | 0.38% |
| Amanat Acquisition Corp | 750K | US$7.99M | 0.36% |
| Inventiva SA | 2.07M | US$7.62M | 0.35% |
| JATT II Acquisition Corp | 683K | US$7.6M | 0.35% |
| Ionis Pharmaceuticals, Inc. | 170K | US$7.57M | 0.35% |
| Rainier Acquisition Corporation | 743K | US$7.55M | 0.34% |
| C4 Therapeutics, Inc. | 2.23M | US$7.44M | 0.34% |
| MapLight Therapeutics, Inc. | 725K | US$7.39M | 0.34% |
| Savara, Inc. | 1.41M | US$7.28M | 0.33% |
| Perspective Therapeutics, Inc. | 2.62M | US$7.2M | 0.33% |
| Silence Therapeutics PLC | 630K | US$6.88M | 0.31% |
| Biohaven Ltd. | 502K | US$6.7M | 0.31% |
| Destiny Tech100 Inc | 210K | US$6.49M | 0.30% |
| TCGX Acquisition Corp. | 500K | US$6.26M | 0.29% |
| Research Alliance Corporation IV | 525K | US$6.22M | 0.28% |
| OnKure Therapeutics, Inc. | 2.24M | US$6.1M | 0.28% |
| CytomX Therapeutics, Inc. | 2.2M | US$6M | 0.27% |
| Pliant Therapeutics, Inc. | 5.51M | US$5.95M | 0.27% |
| Mineralys Therapeutics, Inc. | 227K | US$5.71M | 0.26% |
| Oaktree Acquisition Corp. III Life Sciences | 516K | US$5.62M | 0.26% |
| Equillium, Inc. | 3.45M | US$5.6M | 0.26% |
| Biogen Inc. | 24,400 | US$5.51M | 0.25% |
| Krystal Biotech, Inc. | 16,420 | US$5.46M | 0.25% |
| Korro Bio, Inc. | 540K | US$5.35M | 0.24% |
| Lexeo Therapeutics, Inc. | 1.58M | US$5.33M | 0.24% |
| Contineum Therapeutics, Inc. | 385K | US$5.17M | 0.24% |
| Ardelyx, Inc. | 1.49M | US$5.1M | 0.23% |
| Whitehawk Therapeutics, Inc. | 1.34M | US$5.04M | 0.23% |
| BHAV Acquisition Corp | 495K | US$5.02M | 0.23% |
| JATT III Acquisition Corp | 454K | US$5M | 0.23% |
| Capricor Therapeutics, Inc. | 527K | US$4.99M | 0.23% |
| Prime Medicine, Inc. | 1.6M | US$4.88M | 0.22% |
| Inspire Medical Systems, Inc. | 70,029 | US$4.86M | 0.22% |
| Tarsus Pharmaceuticals, Inc. | 62,500 | US$4.77M | 0.22% |
| MacroGenics, Inc. | 1.23M | US$4.77M | 0.22% |
| Boundless Bio, Inc. | 1.89M | US$4.75M | 0.22% |
| Acumen Pharmaceuticals, Inc. | 2.11M | US$4.69M | 0.21% |
| Danaher Corporation | 21,132 | US$4.68M | 0.21% |
| Alector, Inc. | 2.51M | US$4.65M | 0.21% |
| Pfizer, Inc. | 162K | US$4.63M | 0.21% |
| Arrowhead Pharmaceuticals, Inc. | 69,200 | US$4.53M | 0.21% |